Page last updated: 2024-09-05

sb 203580 and Koch's Disease

sb 203580 has been researched along with Koch's Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Juffermans, NP; Peppelenbosch, MP; Schultz, MJ; ten Hove, T; van den Blink, B; van der Poll, T; van Deventer, SJ1

Other Studies

1 other study(ies) available for sb 203580 and Koch's Disease

ArticleYear
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
    Journal of immunology (Baltimore, Md. : 1950), 2001, Jan-01, Volume: 166, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytokines; Disease Models, Animal; Endotoxemia; Enzyme Inhibitors; Female; Humans; Imidazoles; Injections, Intraperitoneal; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pneumonia, Pneumococcal; Pyridines; Tuberculosis; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Up-Regulation

2001